Skip to main content

Transgenomic Gets SBIR Grant to Develop Technology for Whole-Genome Analysis

NEW YORK (GenomeWeb News) – Transgenomic today said that it has received a $100,000 Small Business Innovation Research grant to support the development of the firm’s Surveyor Endonuclease Adaptor-ligated Libraries technology.
The SEAL technology is a high-throughput method for whole-genome analysis. The Omaha, Neb.-based firm said that it can identify DNA variations between a reference genome and a test genome and could potentially reduce the cost of whole-genome analysis of such variations to under $10,000.
By focusing on regions of DNA variation, the SEAL technology eliminates the sequencing of vast amounts of non-variant DNA, said Transgenomic, but it also is not limited to assessment of known common SNPs.
Craig Tuttle, president and CEO of Transgenomic, said that the grants supports the firm’s belief that its technology “will have a significant impact on whole-genome analysis for pharmacogenomic studies in personalized medicine and bacterial drug resistance research.”
The grant period has a duration of six months.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.